First full results from interim analysis of Oxford COVID-19 vaccine published

Interim analysis of ongoing clinical trials finds the ChAdOx1 nCoV-19 vaccine has an acceptable safety profile and is efficacious against symptomatic COVID-19.

Please sign in or register for FREE

No comments yet.